INDUCTION OF REMISSION OF MILD TO MODERATELY ACTIVE ULCERATIVE COLITIS WITH BUDESONIDE-MMX® 9MG: A MULTICENTRE, RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY IN EUROPE, RUSSIA, ISRAEL AND AUSTRALIA

(1) JOHN RADCLIFFE HOSPITAL

(2) Istituto Clinico Humanitas

(3) Santarus

(4) Cosmo Pharmaceuticals

(5) University of California



This item was part of the New ulcerative colitis therapies session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A22